{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:34:01Z","timestamp":1788381241605,"version":"build-2803163510"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.critrevonc.2023.104058","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T02:10:51Z","timestamp":1687140651000},"page":"104058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Somatic and germline ATM variants in non-small-cell lung cancer: Therapeutic implications"],"prefix":"10.1016","volume":"188","author":[{"given":"Juan-Manuel","family":"Hernandez-Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Rosell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1164-3779","authenticated-orcid":false,"given":"Oscar","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2023.104058_bib1","unstructured":"SEER Cancer Statistics Review, 1973-1993, National Cancer Institute. Bethesda, MD. https:\/\/seer.cancer.gov\/archive\/csr\/1973_1993\/overview.pdf. Accessed January 2023."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104058_bib2","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1158\/1078-0432.CCR-20-0394","article-title":"Non-BRCA DNA damage repair gene alterations and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: analysis from the phase II TRITON2 study","volume":"26","author":"Abida","year":"2020","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","article-title":"The lung microenvironment: an important regulator of tumour growth and metastasis","volume":"19","author":"Altorki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104058_bib4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/1744666X.2020.1810570","article-title":"Ataxia-telangiectasia: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management","volume":"16","author":"Amirifar","year":"2020","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.critrevonc.2023.104058_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1383-5742(00)00034-X","article-title":"The ATM gene and breast cancer: is it really a risk factor?","volume":"462","author":"Angele","year":"2000","journal-title":"Mutat. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1544442","article-title":"PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer","volume":"8","author":"Angell","year":"2019","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104058_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41571-020-0395-x","article-title":"Olaparib for DNA repair-deficient prostate cancer - one for all, or all for one?","volume":"17","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-020-01376-4","article-title":"Radiation-induced lung injury: current evidence","volume":"21","author":"Arroyo-Hernandez","year":"2021","journal-title":"BMC Pulm. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF00291879","article-title":"Probable involvement of immunoglobulin superfamily genes in most recurrent chromosomal rearrangements from ataxia telangiectasia","volume":"72","author":"Aurias","year":"1986","journal-title":"Hum. Genet"},{"key":"10.1016\/j.critrevonc.2023.104058_bib10","doi-asserted-by":"crossref","unstructured":"Bade, B.C., Dela Cruz, C.S., 2020. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med 41(1), 1\u201324.","DOI":"10.1016\/j.ccm.2019.10.001"},{"key":"10.1016\/j.critrevonc.2023.104058_bib11","doi-asserted-by":"crossref","unstructured":"Bailey-Wilson, J.E., Amos, C.I., Pinney, S.M., Petersen, G.M., de Andrade, M., Wiest, J.S., Fain, P., Schwartz, A.G., You, M., Franklin, W., Klein, C., Gazdar, A., Rothschild, H., Mandal, D., Coons, T., Slusser, J., Lee, J., Gaba, C., Kupert, E., Perez, A., Zhou, X., Zeng, D., Liu, Q., Zhang, Q., Seminara, D., Minna, J., Anderson, M.W., 2004. A major lung cancer susceptibility locus maps to chromosome 6q23\u201325. American journal of human genetics 75(3), 460\u2013474.","DOI":"10.1086\/423857"},{"key":"10.1016\/j.critrevonc.2023.104058_bib12","doi-asserted-by":"crossref","unstructured":"Balmus, G., Pilger, D., Coates, J., Demir, M., Sczaniecka-Clift, M., Barros, A.C., Woods, M., Fu, B., Yang, F., Chen, E., Ostermaier, M., Stankovic, T., Ponstingl, H., Herzog, M., Yusa, K., Martinez, F.M., Durant, S.T., Galanty, Y., Beli, P., Adams, D.J., Bradley, A., Metzakopian, E., Forment, J.V., Jackson, S.P., 2019. ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks. Nat Commun 10(1), 87.","DOI":"10.1038\/s41467-018-07729-2"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104058_bib13","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.18632\/oncotarget.694","article-title":"Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN","volume":"3","author":"Beggs","year":"2012","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104058_bib14","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.eururo.2012.08.053","article-title":"Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity","volume":"63","author":"Beltran","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2023.104058_bib15","first-page":"399","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104058_bib16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3109\/08880018.2013.777949","article-title":"Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant","volume":"30","author":"Bielorai","year":"2013","journal-title":"Pedia Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib17","first-page":"363","article-title":"A decade of GWAS results in lung cancer. cancer epidemiology, biomarkers & prevention: a publication of the american association for cancer research, cosponsored by the american society of preventive","volume":"27","author":"Bosse","year":"2018","journal-title":"Oncology"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/jcp.54.7.512","article-title":"Ataxia telangiectasia gene mutations in leukaemia and lymphoma","volume":"54","author":"Boultwood","year":"2001","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2023.104058_bib19","article-title":"Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes","volume":"8","author":"Breast Cancer Association","year":"2022"},{"issue":"17","key":"10.1016\/j.critrevonc.2023.104058_bib20","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.1093\/nar\/gkaa723","article-title":"ATM antagonizes NHEJ proteins assembly and DNA-ends synapsis at single-ended DNA double strand breaks","volume":"48","author":"Britton","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1086\/302746","article-title":"ATM-heterozygous germline mutations contribute to breast cancer-susceptibility","volume":"66","author":"Broeks","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/humu.10158","article-title":"Comprehensive scanning of the ATM gene with DOVAM-S","volume":"21","author":"Buzin","year":"2003","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/bjc.2011.534","article-title":"Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia","volume":"106","author":"Byrd","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104058_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/10409238.2020.1813070","article-title":"Dynamic elements of replication protein A at the crossroads of DNA replication, recombination, and repair","volume":"55","author":"Caldwell","year":"2020","journal-title":"Crit. Rev. Biochem Mol. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V99.1.238","article-title":"ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances","volume":"99","author":"Camacho","year":"2002","journal-title":"Blood"},{"issue":"7511","key":"10.1016\/j.critrevonc.2023.104058_bib26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Cancer Genome Atlas Research, N","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib27","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","author":"Cancer Genome Atlas Research, N","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","author":"Cancer Genome Atlas Research Network. Electronic address, a.a.d.h.e., Cancer Genome Atlas Research, N","year":"2017","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/ccr3.3543","article-title":"Identifying ataxia-telangiectasia in cancer patients: Novel insights from an interesting case and review of literature","volume":"9","author":"Cao","year":"2021","journal-title":"Clin. Case Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<156::AID-HUMU7>3.0.CO;2-E","article-title":"New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy","volume":"14","author":"Castellvi-Bel","year":"1999","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.20101","article-title":"Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families","volume":"42","author":"Cavaciuti","year":"2005","journal-title":"Genes, Chromosomes Cancer"},{"key":"10.1016\/j.critrevonc.2023.104058_bib32","first-page":"4","article-title":"ATM regulation of IL-8 links oxidative stress to cancer cell migration and invasion","author":"Chen","year":"2015","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104058_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.11895","article-title":"Association of tumor protein p53 and ataxia-telangiectasia mutated comutation with response to immune checkpoint inhibitors and mortality in patients with non-small cell lung cancer","volume":"2","author":"Chen","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104058_bib34","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","article-title":"ATM mutations in cancer: therapeutic implications","volume":"15","author":"Choi","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/088307389400900106","article-title":"Cerebral white-matter changes suggesting leukodystrophy in ataxia telangiectasia","volume":"9","author":"Chung","year":"1994","journal-title":"J. Child Neurol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib36","first-page":"525","article-title":"Assessment of clinical benefit of integrative genomic profiling in advanced solid tumors","volume":"7","author":"Cobain","year":"2021","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104058_bib37","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/09553008814552331","volume":"54","author":"Cole","year":"1988","journal-title":"Int J. Radiat. Biol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104058_bib38","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR project GENIE: powering precision medicine through an international consortium","volume":"7","author":"Consortium","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2023.104058_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102895","article-title":"Lung cancer in never smokers: the role of different risk factors other than tobacco smoking","volume":"148","author":"Corrales","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"13","key":"10.1016\/j.critrevonc.2023.104058_bib40","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ejca.2012.01.038","article-title":"Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the international lung cancer consortium","volume":"48","author":"Cote","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib41","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/adc.2006.094268","article-title":"Survival probability in ataxia telangiectasia","volume":"91","author":"Crawford","year":"2006","journal-title":"Arch. Dis. Child"},{"key":"10.1016\/j.critrevonc.2023.104058_bib42","doi-asserted-by":"crossref","unstructured":"Davies, H., Hunter, C., Smith, R., Stephens, P., Greenman, C., Bignell, G., Teague, J., Butler, A., Edkins, S., Stevens, C., Parker, A., O'Meara, S., Avis, T., Barthorpe, S., Brackenbury, L., Buck, G., Clements, J., Cole, J., Dicks, E., Edwards, K., Forbes, S., Gorton, M., Gray, K., Halliday, K., Harrison, R., Hills, K., Hinton, J., Jones, D., Kosmidou, V., Laman, R., Lugg, R., Menzies, A., Perry, J., Petty, R., Raine, K., Shepherd, R., Small, A., Solomon, H., Stephens, Y., Tofts, C., Varian, J., Webb, A., West, S., Widaa, S., Yates, A., Brasseur, F., Cooper, C.S., Flanagan, A.M., Green, A., Knowles, M., Leung, S.Y., Looijenga, L.H., Malkowicz, B., Pierotti, M.A., Teh, B.T., Yuen, S.T., Lakhani, S.R., Easton, D.F., Weber, B.L., Goldstraw, P., Nicholson, A.G., Wooster, R., Stratton, M.R., Futreal, P.A., 2005. Somatic mutations of the protein kinase gene family in human lung cancer. Cancer research 65(17), 7591\u20137595.","DOI":"10.1158\/0008-5472.CAN-05-1855"},{"issue":"22","key":"10.1016\/j.critrevonc.2023.104058_bib43","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0303-8467(94)00048-B","article-title":"An early-onset recessive cerebellar disorder with distal amyotrophy and, in two patients, gross myoclonia: a probable ataxia telangiectasia variant","volume":"97","author":"de Graaf","year":"1995","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.critrevonc.2023.104058_bib45","doi-asserted-by":"crossref","unstructured":"de Koning, H.J., van der Aalst, C.M., de Jong, P.A., Scholten, E.T., Nackaerts, K., Heuvelmans, M.A., Lammers, J.J., Weenink, C., Yousaf-Khan, U., Horeweg, N., van 't Westeinde, S., Prokop, M., Mali, W.P., Mohamed Hoesein, F.A.A., van Ooijen, P.M.A., Aerts, J., den Bakker, M.A., Thunnissen, E., Verschakelen, J., Vliegenthart, R., Walter, J.E., Ten Haaf, K., Groen, H.J.M., Oudkerk, M.., 2020. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. The New England journal of medicine 382(6), 503\u2013513.","DOI":"10.1056\/NEJMoa1911793"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib46","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1200\/JCO.2011.40.1430","article-title":"Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: a case report and review of the literature","volume":"31","author":"DeWire","year":"2013","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104058_bib47","doi-asserted-by":"crossref","unstructured":"Ding, L., Getz, G., Wheeler, D.A., Mardis, E.R., McLellan, M.D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D.M., Morgan, M.B., Fulton, L., Fulton, R.S., Zhang, Q., Wendl, M.C., Lawrence, M.S., Larson, D.E., Chen, K., Dooling, D.J., Sabo, A., Hawes, A.C., Shen, H., Jhangiani, S.N., Lewis, L.R., Hall, O., Zhu, Y., Mathew, T., Ren, Y., Yao, J., Scherer, S.E., Clerc, K., Metcalf, G.A., Ng, B., Milosavljevic, A., Gonzalez-Garay, M.L., Osborne, J.R., Meyer, R., Shi, X., Tang, Y., Koboldt, D.C., Lin, L., Abbott, R., Miner, T.L., Pohl, C., Fewell, G., Haipek, C., Schmidt, H., Dunford-Shore, B.H., Kraja, A., Crosby, S.D., Sawyer, C.S., Vickery, T., Sander, S., Robinson, J., Winckler, W., Baldwin, J., Chirieac, L.R., Dutt, A., Fennell, T., Hanna, M., Johnson, B.E., Onofrio, R.C., Thomas, R.K., Tonon, G., Weir, B.A., Zhao, X., Ziaugra, L., Zody, M.C., Giordano, T., Orringer, M.B., Roth, J.A., Spitz, M.R., Wistuba, I.I., Ozenberger, B., Good, P.J., Chang, A.C., Beer, D.G., Watson, M.A., Ladanyi, M., Broderick, S., Yoshizawa, A., Travis, W.D., Pao, W., Province, M.A., Weinstock, G.M., Varmus, H.E., Gabriel, S.B., Lander, E.S., Gibbs, R.A., Meyerson, M., Wilson, R.K., 2008. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455(7216), 1069\u20131075.","DOI":"10.1038\/nature07423"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104058_bib48","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijrobp.2014.12.041","article-title":"Ataxia telangiectasia-mutated gene polymorphisms and acute normal tissue injuries in cancer patients after radiation therapy: a systematic review and meta-analysis","volume":"91","author":"Dong","year":"2015","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"issue":"6 Suppl","key":"10.1016\/j.critrevonc.2023.104058_bib49","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1080\/09553009414552011","article-title":"Cancer risks in A-T heterozygotes","volume":"66","author":"Easton","year":"1994","journal-title":"Int J. Radiat. Biol."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.104058_bib50","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.jtho.2020.08.017","article-title":"Inherited rare, deleterious variants in ATM increase lung adenocarcinoma risk","volume":"15","author":"Esai Selvan","year":"2020","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13058-015-0575-2","article-title":"Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer","volume":"17","author":"Feng","year":"2015","journal-title":"Breast Cancer Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104058_bib52","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/humu.23778","article-title":"Functional classification of ATM variants in ataxia-telangiectasia patients","volume":"40","author":"Fievet","year":"2019","journal-title":"Hum. Mutat."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104058_bib53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa2214676","article-title":"Rucaparib or physician's choice in metastatic prostate cancer","volume":"388","author":"Fizazi","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40246-019-0234-2","article-title":"Diversity of ATM gene variants: a population-based genome data analysis for precision medicine","volume":"13","author":"Fukunaga","year":"2019","journal-title":"Hum. Genom."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib55","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ijc.24283","article-title":"Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer","volume":"125","author":"Gao","year":"2009","journal-title":"Int. J. Cancer J. Int. du Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semradonc.2021.09.008","article-title":"Targeting the ATM kinase to enhance the efficacy of radiotherapy and outcomes for cancer patients","volume":"32","author":"Garcia","year":"2022","journal-title":"Semin Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib57","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ijc.1329","article-title":"Cancer risk in heterozygotes for ataxia-telangiectasia","volume":"93","author":"Geoffroy-Perez","year":"2001","journal-title":"Int. J. Cancer J. Int. du Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-4608(90)90003-S","article-title":"Cancer in ataxia-telangiectasia patients","volume":"46","author":"Hecht","year":"1990","journal-title":"Cancer Genet. Cytogenet."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104058_bib60","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ni.1735","article-title":"RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci","volume":"10","author":"Hewitt","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2023.104058_bib61","unstructured":"Howlader, N., Noone, A.M., Krapcho, M., Neyman, N., Aminou, R., Waldron, W., Altekruse, S.F., Kosary, C.L., Ruhl, J., Tatalovich, Z., Cho, H., Mariotto, A., Eisner, M.P., Lewis, D.R., Chen, H.S., Feuer, E.J., Cronin, K.A., Edwards, B.K., SEER Cancer Statistics Review, 1975\u20132008, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2008\/, based on November 2010 SEER data submission, posted to the SEER web site, 2011. (Accessed January 2023."},{"key":"10.1016\/j.critrevonc.2023.104058_bib62","first-page":"3","article-title":"DNA repair gene mutations as predictors of immune checkpoint inhibitor response beyond tumor mutation burden","volume":"1","author":"Hsiehchen","year":"2020","journal-title":"Cell Rep. Med"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104058_bib63","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jamaoncol.2021.3701","article-title":"Risk of pancreatic cancer among individuals with pathogenic variants in the ATM Gene","volume":"7","author":"Hsu","year":"2021","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib64","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1021\/acs.molpharmaceut.1c00166","article-title":"Sensors and inhibitors for the detection of ataxia telangiectasia mutated (ATM) protein kinase","volume":"18","author":"Huang","year":"2021","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","article-title":"Pathogenic germline variants in 10,389 adult cancers","volume":"173","author":"Huang","year":"2018","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/gtmb.2015.0320","article-title":"Effect of ATM-111 (G>A) polymorphism on cancer risk: a meta-analysis","volume":"20","author":"Huang","year":"2016","journal-title":"Genet Test. Mol. Biomark."},{"key":"10.1016\/j.critrevonc.2023.104058_bib67","doi-asserted-by":"crossref","unstructured":"Hussain, M., Mateo, J., Fizazi, K., Saad, F., Shore, N., Sandhu, S., Chi, K.N., Sartor, O., Agarwal, N., Olmos, D., Thiery-Vuillemin, A., Twardowski, P., Roubaud, G., Ozguroglu, M., Kang, J., Burgents, J., Gresty, C., Corcoran, C., Adelman, C.A., de Bono, J., Investigators, P.R.T., 2020. Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer. The New England journal of medicine 383(24), 2345\u20132357.","DOI":"10.1056\/NEJMoa2022485"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib68","first-page":"0037","article-title":"Related mechanisms of antibody somatic hypermutation and class switch recombination","volume":"3","author":"Hwang","year":"2015","journal-title":"Microbiol. Spectr. MDNA3"},{"key":"10.1016\/j.critrevonc.2023.104058_bib69","doi-asserted-by":"crossref","unstructured":"Imielinski, M., Berger, A.H., Hammerman, P.S., Hernandez, B., Pugh, T.J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., Sougnez, C., Auclair, D., Lawrence, M.S., Stojanov, P., Cibulskis, K., Choi, K., de Waal, L., Sharifnia, T., Brooks, A., Greulich, H., Banerji, S., Zander, T., Seidel, D., Leenders, F., Ansen, S., Ludwig, C., Engel-Riedel, W., Stoelben, E., Wolf, J., Goparju, C., Thompson, K., Winckler, W., Kwiatkowski, D., Johnson, B.E., Janne, P.A., Miller, V.A., Pao, W., Travis, W.D., Pass, H.I., Gabriel, S.B., Lander, E.S., Thomas, R.K., Garraway, L.A., Getz, G., Meyerson, M., 2012. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150(6), 1107\u20131120.","DOI":"10.1016\/j.cell.2012.08.029"},{"key":"10.1016\/j.critrevonc.2023.104058_bib70","doi-asserted-by":"crossref","unstructured":"Ji, X., Mukherjee, S., Landi, M.T., Bosse, Y., Joubert, P., Zhu, D., Gorlov, I., Xiao, X., Han, Y., Gorlova, O., Hung, R.J., Brhane, Y., Carreras-Torres, R., Christiani, D.C., Caporaso, N., Johansson, M., Liu, G., Bojesen, S.E., Le Marchand, L., Albanes, D., Bickeboller, H., Aldrich, M.C., Bush, W.S., Tardon, A., Rennert, G., Chen, C., Byun, J., Dragnev, K.H., Field, J.K., Kiemeney, L.F., Lazarus, P., Zienolddiny, S., Lam, S., Schabath, M.B., Andrew, A.S., Bertazzi, P.A., Pesatori, A.C., Diao, N., Su, L., Song, L., Zhang, R., Leighl, N., Johansen, J.S., Mellemgaard, A., Saliba, W., Haiman, C., Wilkens, L., Fernandez-Somoano, A., Fernandez-Tardon, G., Heijden, E., Kim, J.H., Davies, M.P.A., Marcus, M.W., Brunnstrom, H., Manjer, J., Melander, O., Muller, D.C., Overvad, K., Trichopoulou, A., Tumino, R., Goodman, G.E., Cox, A., Taylor, F., Woll, P., Wichmann, E., Muley, T., Risch, A., Rosenberger, A., Grankvist, K., Johansson, M., Shepherd, F., Tsao, M.S., Arnold, S.M., Haura, E.B., Bolca, C., Holcatova, I., Janout, V., Kontic, M., Lissowska, J., Mukeria, A., Ognjanovic, S., Orlowski, T.M., Scelo, G., Swiatkowska, B., Zaridze, D., Bakke, P., Skaug, V., Butler, L.M., Offit, K., Srinivasan, P., Bandlamudi, C., Hellmann, M.D., Solit, D.B., Robson, M.E., Rudin, C.M., Stadler, Z.K., Taylor, B.S., Berger, M.F., Houlston, R., McLaughlin, J., Stevens, V., Nickle, D.C., Obeidat, M., Timens, W., Artigas, M.S., Shete, S., Brenner, H., Chanock, S., Brennan, P., McKay, J.D., Amos, C.I., 2020. Protein-altering germline mutations implicate novel genes related to lung cancer development. Nat Commun 11(1), 2220.","DOI":"10.1038\/s41467-020-15905-6"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/BJ20112100","article-title":"Replication fork dynamics and the DNA damage response","volume":"443","author":"Jones","year":"2012","journal-title":"Biochem. J."},{"issue":"24","key":"10.1016\/j.critrevonc.2023.104058_bib72","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1001\/jama.292.24.2977","article-title":"Familial risk of lung carcinoma in the Icelandic population","volume":"292","author":"Jonsson","year":"2004","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.critrevonc.2023.104058_bib73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mrfmmm.2007.08.013","article-title":"Expression status of ataxia-telangiectasia-mutated gene correlated with prognosis in advanced gastric cancer","volume":"638","author":"Kang","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.critrevonc.2023.104058_bib74","doi-asserted-by":"crossref","unstructured":"Karlsson, Q., Brook, M.N., Dadaev, T., Wakerell, S., Saunders, E.J., Muir, K., Neal, D.E., Giles, G.G., MacInnis, R.J., Thibodeau, S.N., McDonnell, S.K., Cannon-Albright, L., Teixeira, M.R., Paulo, P., Cardoso, M., Huff, C., Li, D., Yao, Y., Scheet, P., Permuth, J.B., Stanford, J.L., Dai, J.Y., Ostrander, E.A., Cussenot, O., Cancel-Tassin, G., Hoegel, J., Herkommer, K., Schleutker, J., Tammela, T.L.J., Rathinakannan, V., Sipeky, C., Wiklund, F., Gronberg, H., Aly, M., Isaacs, W.B., Dickinson, J.L., FitzGerald, L.M., Chua, M.L.K., Nguyen-Dumont, T., Consortium, P., Schaid, D.J., Southey, M.C., Eeles, R.A., Kote-Jarai, Z., 2021. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study. Eur Urol Oncol 4(4), 570\u2013579.","DOI":"10.1016\/j.euo.2020.12.001"},{"key":"10.1016\/j.critrevonc.2023.104058_bib75","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/159269","article-title":"Myeloid-derived suppressor cells and therapeutic strategies in cancer","volume":"2015","author":"Katoh","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib76","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/hmg\/ddl033","article-title":"Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk","volume":"15","author":"Kim","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib77","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.annonc.2021.10.009","article-title":"Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced\/metastatic melanoma who have failed prior anti-PD-1 therapy","volume":"33","author":"Kim","year":"2022","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol. \/ ESMO"},{"issue":"17","key":"10.1016\/j.critrevonc.2023.104058_bib78","first-page":"4700","article-title":"Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer. Clinical cancer research","volume":"27","author":"Kim","year":"2021","journal-title":"An official journal of the American Association for Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib79","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00291379","article-title":"Tissue specificity of chromosomal rearrangements in ataxia-telangiectasia","volume":"83","author":"Kojis","year":"1989","journal-title":"Hum. Genet"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib80","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1470-2045(20)30180-7","article-title":"Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial","volume":"21","author":"Konstantinopoulos","year":"2020","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib81","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1038\/s41467-021-25904-w","article-title":"A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer","volume":"12","author":"Konstantinopoulos","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2023.104058_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.16.00066","article-title":"Breast and ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women","volume":"1","author":"Kurian","year":"2017","journal-title":"JCO Precis Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib83","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bjc.6605134","article-title":"Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array","volume":"101","author":"Kweekel","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104058_bib84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/jitc-2022-005041","article-title":"Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer","volume":"10","author":"Kwon","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104058_bib85","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrm2514","article-title":"Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer","volume":"9","author":"Lavin","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104058_bib86","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1200\/JCO.2005.04.4206","article-title":"Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer","volume":"24","author":"Li","year":"2006","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib87","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.gene.2013.12.028","article-title":"DNA repair pathway genes and lung cancer susceptibility: a meta-analysis","volume":"538","author":"Li","year":"2014","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib88","doi-asserted-by":"crossref","first-page":"446","DOI":"10.21037\/atm.2020.03.163","article-title":"Novel tumor mutation score versus tumor mutation burden in predicting survival after immunotherapy in pan-cancer patients from the MSK-IMPACT cohort","volume":"8","author":"Li","year":"2020","journal-title":"Ann. Transl. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib89","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2017.08.030","article-title":"Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls","volume":"147","author":"Lilyquist","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104058_bib90","doi-asserted-by":"crossref","unstructured":"Lindor, N.M., McMaster, M.L., Lindor, C.J., Greene, M.H., National Cancer Institute, D.o.C.P.C.O., Prevention Trials Research, G, 2008. Concise handbook of familial cancer susceptibility syndromes - second edition. J Natl Cancer Inst Monogr(38), 1\u201393.","DOI":"10.1093\/jncimonographs\/lgn001"},{"issue":"18","key":"10.1016\/j.critrevonc.2023.104058_bib91","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/s41388-017-0121-z","article-title":"Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis","volume":"37","author":"Lindstrom","year":"2018","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib92","doi-asserted-by":"crossref","first-page":"646","DOI":"10.21037\/tlcr-19-403","article-title":"The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility","volume":"9","author":"Liu","year":"2020","journal-title":"Transl. Lung Cancer Res"},{"key":"10.1016\/j.critrevonc.2023.104058_bib93","first-page":"12","article-title":"Rare deleterious germline variants and risk of lung cancer","volume":"5","author":"Liu","year":"2021"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib94","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.lungcan.2009.11.007","article-title":"ATM polymorphisms and risk of lung cancer among never smokers","volume":"69","author":"Lo","year":"2010","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib95","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00415-015-7762-z","article-title":"Clinical variability in ataxia-telangiectasia","volume":"262","author":"Lohmann","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.critrevonc.2023.104058_bib96","doi-asserted-by":"crossref","unstructured":"Lu, C., Xie, M., Wendl, M.C., Wang, J., McLellan, M.D., Leiserson, M.D., Huang, K.L., Wyczalkowski, M.A., Jayasinghe, R., Banerjee, T., Ning, J., Tripathi, P., Zhang, Q., Niu, B., Ye, K., Schmidt, H.K., Fulton, R.S., McMichael, J.F., Batra, P., Kandoth, C., Bharadwaj, M., Koboldt, D.C., Miller, C.A., Kanchi, K.L., Eldred, J.M., Larson, D.E., Welch, J.S., You, M., Ozenberger, B.A., Govindan, R., Walter, M.J., Ellis, M.J., Mardis, E.R., Graubert, T.A., Dipersio, J.F., Ley, T.J., Wilson, R.K., Goodfellow, P.J., Raphael, B.J., Chen, F., Johnson, K.J., Parvin, J.D., Ding, L., 2015. Patterns and functional implications of rare germline variants across 12 cancer types. Nat Commun 6, 10086.","DOI":"10.1038\/ncomms10086"},{"key":"10.1016\/j.critrevonc.2023.104058_bib97","first-page":"5","article-title":"Ceralasertib-mediated ATR inhibition combined with olaparib in advanced cancers harboring DNA damage response and repair alterations (Olaparib Combinations)","author":"Mahdi","year":"2021","journal-title":"JCO Precis Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib98","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.eururo.2019.02.002","article-title":"Differential response to olaparib treatment among men with metastatic castration-resistant prostate cancer harboring BRCA1 or BRCA2 versus ATM mutations","volume":"76","author":"Marshall","year":"2019","journal-title":"Eur. Urol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib99","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjc.6602769","article-title":"Systematic review of the relationship between family history and lung cancer risk","volume":"93","author":"Matakidou","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104058_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800267-4.00001-8","article-title":"Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair","volume":"122","author":"Matthews","year":"2014","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib101","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41467-018-03730-x","article-title":"Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers","volume":"9","author":"McGrail","year":"2018","journal-title":"Nat. Commun."},{"issue":"6280","key":"10.1016\/j.critrevonc.2023.104058_bib102","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13045-019-0733-6","article-title":"Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand","volume":"12","author":"Mei","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104058_bib104","first-page":"382","article-title":"Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype","volume":"128","author":"Micol","year":"2011"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib105","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41416-021-01405-x","article-title":"Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine +\/- cisplatin in patients with advanced solid tumours","volume":"125","author":"Middleton","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"Pt 6","key":"10.1016\/j.critrevonc.2023.104058_bib106","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1529-8817.2005.00199.x","article-title":"ATM gene founder haplotypes and associated mutations in Polish families with ataxia-telangiectasia","volume":"69","author":"Mitui","year":"2005","journal-title":"Ann. Hum. Genet"},{"key":"10.1016\/j.critrevonc.2023.104058_bib107","doi-asserted-by":"crossref","unstructured":"Morio, T., Takahashi, N., Watanabe, F., Honda, F., Sato, M., Takagi, M., Imadome, K.I., Miyawaki, T., Delia, D., Nakamura, K., Gatti, R.A., Mizutani, S., 2009. Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan. Int J Hematol 90(4), 455\u2013462.","DOI":"10.1007\/s12185-009-0408-0"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib108","first-page":"89","article-title":"Mortality and cancer incidence in 263 patients with ataxia-telangiectasia","volume":"77","author":"Morrell","year":"1986","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104058_bib109","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.18632\/aging.103094","article-title":"ATM gene polymorphisms are associated with poor prognosis of non-small cell lung cancer receiving radiation therapy","volume":"12","author":"Mou","year":"2020","journal-title":"Aging"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1158\/2159-8290.CD-17-0226","article-title":"DNA damage and repair biomarkers of immunotherapy response","volume":"7","author":"Mouw","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2023.104058_bib111","doi-asserted-by":"crossref","unstructured":"Mucci, L.A., Hjelmborg, J.B., Harris, J.R., Czene, K., Havelick, D.J., Scheike, T., Graff, R.E., Holst, K., Moller, S., Unger, R.H., McIntosh, C., Nuttall, E., Brandt, I., Penney, K.L., Hartman, M., Kraft, P., Parmigiani, G., Christensen, K., Koskenvuo, M., Holm, N.V., Heikkila, K., Pukkala, E., Skytthe, A., Adami, H.O., Kaprio, J., Nordic Twin Study of Cancer, C, 2016. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. JAMA 315(1), 68\u201376.","DOI":"10.1001\/jama.2015.17703"},{"key":"10.1016\/j.critrevonc.2023.104058_bib112","first-page":"1450","article-title":"Germline pathogenic variants impact clinicopathology of advanced lung cancer. cancer epidemiology, biomarkers & prevention: a publication of the american association for cancer research, cosponsored by the american society of preventive","volume":"31","author":"Mukherjee","year":"2022"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104058_bib113","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jtho.2019.05.044","article-title":"Lung cancer incidence and mortality with extended follow-up in the national lung screening trial","volume":"14","author":"National Lung Screening Trial Research, T","year":"2019","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104058_bib114","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"National Lung Screening Trial Research, T","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","article-title":"Immunodeficiency and infections in ataxia-telangiectasia","volume":"144","author":"Nowak-Wegrzyn","year":"2004","journal-title":"J. Pedia"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib116","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1158\/1078-0432.CCR-07-1520","article-title":"Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer","volume":"14","author":"Okazaki","year":"2008","journal-title":"Clin. Cancer Res. Official J. Am. Assoc. Cancer Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104058_bib117","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/jamaoncol.2021.3441","article-title":"Effect of cisplatin and gemcitabine with or without berzosertib in patients with advanced urothelial carcinoma: a phase 2 randomized clinical trial","volume":"7","author":"Pal","year":"2021","journal-title":"JAMA Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104058_bib118","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jtho.2017.08.011","article-title":"Germline mutations in DNA repair genes in lung adenocarcinoma","volume":"12","author":"Parry","year":"2017","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib119","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/annonc\/mdz117","article-title":"Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy","volume":"30","author":"Pastorino","year":"2019","journal-title":"Annal. Oncol. official J. Euro. Soc. Med. Oncol. ESMO"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib120","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/s41467-022-28840-5","article-title":"Clinical and genomic features of Chinese lung cancer patients with germline mutations","volume":"13","author":"Peng","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib121","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas","volume":"20","author":"Pennington","year":"2014","journal-title":"Clin. Cancer Res. Official J. Am. Assoc. Cancer Res."},{"issue":"24","key":"10.1016\/j.critrevonc.2023.104058_bib122","doi-asserted-by":"crossref","first-page":"38326","DOI":"10.18632\/oncotarget.16215","article-title":"Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC","volume":"8","author":"Petersen","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264177","article-title":"The natural history of ataxia-telangiectasia (A-T): a systematic review","volume":"17","author":"Petley","year":"2022","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib124","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","article-title":"State-of-the-art strategies for targeting the DNA damage response in cancer","volume":"16","author":"Pilie","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104058_bib125","doi-asserted-by":"crossref","unstructured":"Pitter, K.L., Casey, D.L., Lu, Y.C., Hannum, M., Zhang, Z., Song, X., Pecorari, I., McMillan, B., Ma, J., Samstein, R.M., Pei, I.X., Khan, A.J., Braunstein, L.Z., Morris, L.G.T., Barker, C.A., Rimner, A., Alektiar, K.M., Romesser, P.B., Crane, C.H., Yahalom, J., Zelefsky, M.J., Scher, H.I., Bernstein, J.L., Mandelker, D.L., Weigelt, B., Reis-Filho, J.S., Lee, N.Y., Powell, S.N., Chan, T.A., Riaz, N., Setton, J., 2021. Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy. J Natl Cancer Inst 113(3), 266\u2013273.","DOI":"10.1093\/jnci\/djaa095"},{"key":"10.1016\/j.critrevonc.2023.104058_bib126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2021.11.011","article-title":"A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer","volume":"163","author":"Plummer","year":"2022","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib127","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/bjc.2011.266","article-title":"Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours","volume":"105","author":"Reiman","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104058_bib128","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles","volume":"38","author":"Renwick","year":"2006","journal-title":"Nat. Genet."},{"issue":"15","key":"10.1016\/j.critrevonc.2023.104058_bib129","first-page":"4135","article-title":"Impact of DNA damage response and repair (DDR) gene mutations on efficacy of PD-(L)1 immune checkpoint inhibition in non-small cell lung cancer","volume":"26","author":"Ricciuti","year":"2020","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104058_bib130","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1001\/jama.1982.03330110042023","article-title":"Fetal proteins in ataxia-telangiectasia","volume":"248","author":"Richkind","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2023.104058_bib131","doi-asserted-by":"crossref","unstructured":"Rizvi, H., Sanchez-Vega, F., La, K., Chatila, W., Jonsson, P., Halpenny, D., Plodkowski, A., Long, N., Sauter, J.L., Rekhtman, N., Hollmann, T., Schalper, K.A., Gainor, J.F., Shen, R., Ni, A., Arbour, K.C., Merghoub, T., Wolchok, J., Snyder, A., Chaft, J.E., Kris, M.G., Rudin, C.M., Socci, N.D., Berger, M.F., Taylor, B.S., Zehir, A., Solit, D.B., Arcila, M.E., Ladanyi, M., Riely, G.J., Schultz, N., Hellmann, M.D., 2018. Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 36(7), 633\u2013641.","DOI":"10.1200\/JCO.2017.75.3384"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib132","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.104058_bib133","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1158\/1078-0432.CCR-04-2378","article-title":"Methylation profiling of archived non-small cell lung cancer: a promising prognostic system","volume":"11","author":"Safar","year":"2005","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"6404","key":"10.1016\/j.critrevonc.2023.104058_bib134","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.aap9346","article-title":"An intrinsic S\/G(2) checkpoint enforced by ATR","volume":"361","author":"Saldivar","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/pbc.24696","article-title":"Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies","volume":"61","author":"Sandlund","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"issue":"20","key":"10.1016\/j.critrevonc.2023.104058_bib136","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1093\/hmg\/ddac123","article-title":"Rare germline deleterious variants increase susceptibility for lung cancer","volume":"31","author":"Sang","year":"2022","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib137","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41467-017-01883-9","article-title":"DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells","volume":"8","author":"Sato","year":"2017","journal-title":"Nat. Commun."},{"issue":"5218","key":"10.1016\/j.critrevonc.2023.104058_bib138","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A single ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib139","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.V94.2.748","article-title":"Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia","volume":"94","author":"Schaffner","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2023.104058_bib140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2021.02.035","article-title":"Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis","volume":"149","author":"Schettini","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib141","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.arcmed.2007.08.004","article-title":"Detection of ATM gene mutations in young lung cancer patients: a population-based control study","volume":"39","author":"Schneider","year":"2008","journal-title":"Arch. Med. Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.104058_bib142","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejmg.2016.05.012","article-title":"Treatment of acute leukemia in children with ataxia telangiectasia (A-T)","volume":"59","author":"Schoenaker","year":"2016","journal-title":"Eur. J. Med Genet"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib143","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ana.25394","article-title":"Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia","volume":"85","author":"Schon","year":"2019","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib144","first-page":"105","article-title":"Ataxia-telangiectasia: a clinical and laboratory review study of 14 cases","volume":"18","author":"Schwartzman","year":"1990","journal-title":"Allergol. Immunopathol."},{"issue":"32","key":"10.1016\/j.critrevonc.2023.104058_bib145","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1200\/JCO.20.01755","article-title":"Two steps forward and one step back for precision in prostate cancer treatment","volume":"38","author":"Schweizer","year":"2020","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib146","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2021.08.024","article-title":"Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer","volume":"163","author":"Shah","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib147","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41416-021-01406-w","article-title":"Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours","volume":"125","author":"Shapiro","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib148","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/0971-5851.95145","article-title":"Ataxia telangiectasia: a report of two cousins and review of literature","volume":"32","author":"Sharma","year":"2011","journal-title":"Indian J. Med Paediatr. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib149","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ijc.25318","article-title":"Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia","volume":"128","author":"Shi","year":"2011","journal-title":"Int. J. Cancer J. Int. du Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib151","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"55","key":"10.1016\/j.critrevonc.2023.104058_bib152","doi-asserted-by":"crossref","first-page":"30499","DOI":"10.18632\/oncotarget.25369","article-title":"Targeted next generation sequencing identified a high frequency genetic mutated profile in wood smoke exposure-related lung adenocarcinoma patients","volume":"9","author":"Soca-Chafre","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2023.104058_bib153","doi-asserted-by":"crossref","unstructured":"Stadler, Z.K., Maio, A., Chakravarty, D., Kemel, Y., Sheehan, M., Salo-Mullen, E., Tkachuk, K., Fong, C.J., Nguyen, B., Erakky, A., Cadoo, K., Liu, Y., Carlo, M.I., Latham, A., Zhang, H., Kundra, R., Smith, S., Galle, J., Aghajanian, C., Abu-Rustum, N., Varghese, A., O'Reilly, E.M., Morris, M., Abida, W., Walsh, M., Drilon, A., Jayakumaran, G., Zehir, A., Ladanyi, M., Ceyhan-Birsoy, O., Solit, D.B., Schultz, N., Berger, M.F., Mandelker, D., Diaz, L.A., {C}Jr.{C}, Offit, K., Robson, M.E., 2021. Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 39(24), 2698\u20132709.","DOI":"10.1200\/JCO.20.03661"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104058_bib154","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1080\/1042819021000002884","article-title":"ATM mutations in sporadic lymphoid tumours","volume":"43","author":"Stankovic","year":"2002","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2249.2008.03684.x","article-title":"Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene","volume":"153","author":"Staples","year":"2008","journal-title":"Clin. Exp. Immunol."},{"issue":"20","key":"10.1016\/j.critrevonc.2023.104058_bib156","first-page":"4552","article-title":"Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia","volume":"58","author":"Starostik","year":"1998","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib157","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.eururo.2020.09.024","article-title":"Efficacy of PARP inhibition in metastatic castration-resistant prostate cancer is very different with non-BRCA DNA repair alterations: reconstructing prespecified endpoints for cohort b from the phase 3 profound trial of olaparib","volume":"79","author":"Stopsack","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2023.104058_bib158","doi-asserted-by":"crossref","unstructured":"Stopsack, K.H., Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang's Letter to the Editor re: Konrad H. Stopsack. Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib. Eur Urol. In press. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.024. Eur Urol 79(3), e81-e82.","DOI":"10.1016\/j.eururo.2020.12.018"},{"key":"10.1016\/j.critrevonc.2023.104058_bib159","doi-asserted-by":"crossref","unstructured":"Stray-Pedersen, A., Borresen-Dale, A.L., Paus, E., Lindman, C.R., Burgers, T., Abrahamsen, T.G., 2007. Alpha fetoprotein is increasing with age in ataxia-telangiectasia. Eur J Paediatr Neurol 11(6), 375\u2013380.","DOI":"10.1016\/j.ejpn.2007.04.001"},{"key":"10.1016\/j.critrevonc.2023.104058_bib160","first-page":"281","article-title":"Genetic polymorphisms and treatment response in advanced non-small cell lung cancer","volume":"56","author":"Su","year":"2007"},{"key":"10.1016\/j.critrevonc.2023.104058_bib161","first-page":"770","article-title":"Mortality rates among carriers of ataxia-telangiectasia mutant alleles","volume":"133","author":"Su","year":"2000"},{"key":"10.1016\/j.critrevonc.2023.104058_bib162","doi-asserted-by":"crossref","unstructured":"Suarez, F., Mahlaoui, N., Canioni, D., Andriamanga, C., Dubois d'Enghien, C., Brousse, N., Jais, J.P., Fischer, A., Hermine, O., Stoppa-Lyonnet, D., 2015. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 33(2), 202\u2013208.","DOI":"10.1200\/JCO.2014.56.5101"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib163","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0022-3476(78)80440-5","article-title":"Plasma levels of carcinoembryonic antigen in patients with ataxia-telangiectasia","volume":"92","author":"Sugimoto","year":"1978","journal-title":"J. Pedia"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib164","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10549-016-3869-x","article-title":"Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer","volume":"158","author":"Suh","year":"2016","journal-title":"Breast Cancer Res Treat."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104058_bib165","article-title":"ATM mutations as an independent prognostic factor and potential biomarker for immune checkpoint therapy in endometrial cancer","volume":"216","author":"Sun","year":"2020","journal-title":"Pathol. Res Pr."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib166","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2019.02.003","article-title":"ATM mutation spectrum in Russian children with ataxia-telangiectasia","volume":"63","author":"Suspitsin","year":"2020","journal-title":"Eur. J. Med Genet"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib168","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-4608(90)90004-T","article-title":"Cancer predisposition of ataxia-telangiectasia heterozygotes","volume":"46","author":"Swift","year":"1990","journal-title":"Cancer Genet. Cytogenet."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104058_bib169","first-page":"3188","volume":"17","author":"Swift","year":"2008","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104058_bib170","first-page":"573","article-title":"The incidence and gene frequency of ataxia-telangiectasia in the United States","volume":"39","author":"Swift","year":"1986","journal-title":"Am. J. Hum. Genet."},{"issue":"26","key":"10.1016\/j.critrevonc.2023.104058_bib171","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1056\/NEJM199112263252602","article-title":"Incidence of cancer in 161 families affected by ataxia-telangiectasia","volume":"325","author":"Swift","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2023.104058_bib172","doi-asserted-by":"crossref","unstructured":"Tate, J.G., Bamford, S., Jubb, H.C., Sondka, Z., Beare, D.M., Bindal, N., Boutselakis, H., Cole, C.G., Creatore, C., Dawson, E., Fish, P., Harsha, B., Hathaway, C., Jupe, S.C., Kok, C.Y., Noble, K., Ponting, L., Ramshaw, C.C., Rye, C.E., Speedy, H.E., Stefancsik, R., Thompson, S.L., Wang, S., Ward, S., Campbell, P.J., Forbes, S.A., 2019. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic acids research 47(D1), D941-D947.","DOI":"10.1093\/nar\/gky1015"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib173","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/cge.12453","article-title":"Ataxia telangiectasia: more variation at clinical and cellular levels","volume":"87","author":"Taylor","year":"2015","journal-title":"Clin. Genet"},{"issue":"10299","key":"10.1016\/j.critrevonc.2023.104058_bib174","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104058_bib175","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jnci\/dji141","article-title":"Cancer risks and mortality in heterozygous ATM mutation carriers","volume":"97","author":"Thompson","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"15","key":"10.1016\/j.critrevonc.2023.104058_bib176","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1200\/JCO.2005.04.8033","article-title":"Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity","volume":"24","author":"Toh","year":"2006","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104058_bib177","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.critrevonc.2023.104058_bib178","doi-asserted-by":"crossref","unstructured":"Tung, N.M., Robson, M.E., Ventz, S., Santa-Maria, C.A., Nanda, R., Marcom, P.K., Shah, P.D., Ballinger, T.J., Yang, E.S., Vinayak, S., Melisko, M., Brufsky, A., DeMeo, M., Jenkins, C., Domchek, S., D'Andrea, A., Lin, N.U., Hughes, M.E., Carey, L.A., Wagle, N., Wulf, G.M., Krop, I.E., Wolff, A.C., Winer, E.P., Garber, J.E., 2020. TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 38(36), 4274\u20134282.","DOI":"10.1200\/JCO.20.02151"},{"issue":"13","key":"10.1016\/j.critrevonc.2023.104058_bib179","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa2211807","article-title":"Helicobacter pylori, homologous-recombination genes, and gastric cancer","volume":"388","author":"Usui","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104058_bib180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/cge.12710","article-title":"Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline","volume":"90","author":"van Os","year":"2016","journal-title":"Clin. Genet"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104058_bib181","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jmedgenet-2018-105635","article-title":"Genotype-phenotype correlations in ataxia telangiectasia patients with ATM c.3576G>A and c.8147T>C mutations","volume":"56","author":"van Os","year":"2019","journal-title":"J. Med Genet"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib182","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1212\/WNL.0000000000006700","article-title":"Trajectories of motor abnormalities in milder phenotypes of ataxia telangiectasia","volume":"92","author":"van Os","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.critrevonc.2023.104058_bib183","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clim.2017.01.009","article-title":"Ataxia-telangiectasia: immunodeficiency and survival","volume":"178","author":"van Os","year":"2017","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib184","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00415-019-09641-1","article-title":"Classic ataxia-telangiectasia: the phenotype of long-term survivors","volume":"267","author":"van Os","year":"2020","journal-title":"J. Neurol."},{"issue":"14","key":"10.1016\/j.critrevonc.2023.104058_bib185","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1200\/JCO.21.02304","article-title":"Controlling the control arm in metastatic castration-resistant prostate cancer trials: best standard of care or the minimum standard of care?","volume":"40","author":"Van Wambeke","year":"2022","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib186","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/humu.22016","article-title":"Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study","volume":"33","author":"Verhagen","year":"2012","journal-title":"Hum. Mutat."},{"issue":"36","key":"10.1016\/j.critrevonc.2023.104058_bib187","doi-asserted-by":"crossref","first-page":"57714","DOI":"10.18632\/oncotarget.9757","article-title":"ATM protein is deficient in over 40% of lung adenocarcinomas","volume":"7","author":"Villaruz","year":"2016","journal-title":"Oncotarget"},{"issue":"7787","key":"10.1016\/j.critrevonc.2023.104058_bib188","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(72)92717-1","article-title":"Serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia","volume":"2","author":"Waldmann","year":"1972","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib189","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.1038\/s41598-017-07737-0","article-title":"Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"38","key":"10.1016\/j.critrevonc.2023.104058_bib190","doi-asserted-by":"crossref","first-page":"60807","DOI":"10.18632\/oncotarget.11845","article-title":"Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer","volume":"7","author":"Weber","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib191","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2307\/3578071","article-title":"Assessment of chronic gamma radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia","volume":"128","author":"Weeks","year":"1991","journal-title":"Radiat. Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104058_bib192","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0303-8467(87)80045-8","article-title":"Ataxia telangiectasia in Chinese children. A clinical and electrophysiological study","volume":"89","author":"Wong","year":"1987","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104058_bib193","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF00210809","article-title":"Unusual features in the inheritance of ataxia telangiectasia","volume":"84","author":"Woods","year":"1990","journal-title":"Hum. Genet"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104058_bib194","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1111\/cas.15108","article-title":"WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade","volume":"112","author":"Wu","year":"2021","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib195","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ijrobp.2012.09.024","article-title":"ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy","volume":"85","author":"Xiong","year":"2013","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib196","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00795-020-00247-5","article-title":"ATM kinase regulates tumor immunoreactions in lymphocyte-predominant breast cancer through modulation of NKG2D ligand and TNF cytokines on tumor cells","volume":"53","author":"Xu","year":"2020","journal-title":"Med Mol. Morphol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104058_bib197","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.prp.2017.07.003","article-title":"A meta-analysis of the relationship between ataxia-telangiectasia mutated gene polymorphisms and lung cancer susceptibility","volume":"213","author":"Xu","year":"2017","journal-title":"Pathol. Res Pr."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104058_bib198","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12890-017-0555-7","article-title":"Association between ATM gene polymorphisms, lung cancer susceptibility and radiation-induced pneumonitis: a meta-analysis","volume":"17","author":"Yan","year":"2017","journal-title":"BMC Pulm. Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104058_bib199","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ijrobp.2009.12.042","article-title":"Association of P53 and ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patients treated with radiotherapy","volume":"79","author":"Yang","year":"2011","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib200","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1017\/S0317167100007794","article-title":"Ataxia-telangiectasia: atypical presentation and toxicity of cancer treatment","volume":"36","author":"Yanofsky","year":"2009","journal-title":"Can. J. Neurol. Sci."},{"issue":"19","key":"10.1016\/j.critrevonc.2023.104058_bib201","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1158\/1078-0432.CCR-21-1032","article-title":"Ceralasertib (AZD6738), an oral ATR kinase inhibitor, in combination with carboplatin in patients with advanced solid tumors: a phase i study","volume":"27","author":"Yap","year":"2021","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"27","key":"10.1016\/j.critrevonc.2023.104058_bib202","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1200\/JCO.19.02404","article-title":"Phase I trial of first-in-class ATR inhibitor M6620 (VX-970) as monotherapy or in combination with carboplatin in patients with advanced solid tumors","volume":"38","author":"Yap","year":"2020","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104058_bib203","doi-asserted-by":"crossref","unstructured":"Yap, T.A., Tan, D.S.P., Terbuch, A., Caldwell, R., Guo, C., Goh, B.C., Heong, V., Haris, N.R.M., Bashir, S., Drew, Y., Hong, D.S., Meric-Bernstam, F., Wilkinson, G., Hreiki, J., Wengner, A.M., Bladt, F., Schlicker, A., Ludwig, M., Zhou, Y., Liu, L., Bordia, S., Plummer, R., Lagkadinou, E., de Bono, J.S., 2021b. First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors. Cancer discovery 11(1), 80\u201391.","DOI":"10.1158\/2159-8290.CD-20-0868"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104058_bib204","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrc.2016.154","article-title":"Targeting neoantigens to augment antitumour immunity","volume":"17","author":"Yarchoan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104058_bib205","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.onc.1201603","article-title":"ATM is usually rearranged in T-cell prolymphocytic leukaemia","volume":"16","author":"Yuille","year":"1998","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104058_bib206","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00011-018-1142-y","article-title":"Inflammation, a significant player of Ataxia-Telangiectasia pathogenesis?","volume":"67","author":"Zaki-Dizaji","year":"2018","journal-title":"Inflamm. Res"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104058_bib207","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jamaoncol.2022.0373","article-title":"Association of pathogenic variants in hereditary cancer genes with multiple diseases","volume":"8","author":"Zeng","year":"2022","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104058_bib208","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ijrobp.2009.07.1675","article-title":"ATM polymorphisms are associated with risk of radiation-induced pneumonitis","volume":"77","author":"Zhang","year":"2010","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"issue":"15","key":"10.1016\/j.critrevonc.2023.104058_bib209","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-19-0761","article-title":"Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy","volume":"79","author":"Zhang","year":"2019","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.critrevonc.2023.104058_bib210","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003267","article-title":"Single nucleotide polymorphism rs1801516 in ataxia telangiectasia-mutated gene predicts late fibrosis in cancer patients after radiotherapy: A PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Zhang","year":"2016","journal-title":"Medicine"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823001464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823001464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:49:58Z","timestamp":1760903398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842823001464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":210,"alternative-id":["S1040842823001464"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104058","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatic and germline ATM variants in non-small-cell lung cancer: Therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104058"}}